Du Yue, Sun Ting-Ting, Hou Ling, Guo Jin-Jie, Wang Xiu-Li, Wu Yu-Bin
, Shenyang, China.
Pediatric Nephrology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, China.
World J Pediatr. 2015 Nov;11(4):346-51. doi: 10.1007/s12519-014-0532-7. Epub 2014 Dec 1.
This study was to evaluate the relative applicability of the most commonly used estimation formulas for renal glomerular filtration rate (GFR) of Chinese children with chronic kidney disease (CKD).
One hundred CKD patients of less than 17 years old were divided into two groups by sex which was further categorized into five subgroups based on CKD staging according to the "reference" GFR (rGFR) determined by Tc-99m-DTPA renal dynamic imaging. Four GFR markers including serum cystatin C (CysC), β2-microglobulin, creatinine, and blood urea nitrogen were measured.
Among all four markers, CysC best reflected the extent of glomerular damages for CKD stage 1. The value for estimation of GFR (eGFR) was derived from five different formulas either over-estimated or underestimated GFR as referenced to rGFR, and the extent of deviations was dependent on gender, age and CKD stage. The Counahan-Barratt formula and the Schwartz formula gave the most accurate estimations of GFR for CKD stages 1 and 2-3, respectively regardless of gender and age differences. Receiver operating characteristic analyses indicated that the Counahan-Barratt formula has the highest diagnostic accuracy.
The Counahan-Barratt formula provides the best approximation to rGFR, thereby the highest applicability to Chinese children with CKD of different genders, ages and CKD stages.
本研究旨在评估中国慢性肾脏病(CKD)患儿中最常用的肾小球滤过率(GFR)估算公式的相对适用性。
100名17岁以下的CKD患者按性别分为两组,再根据Tc-99m-DTPA肾动态显像测定的“参考”GFR(rGFR),按CKD分期进一步分为五个亚组。检测了包括血清胱抑素C(CysC)、β2-微球蛋白、肌酐和血尿素氮在内的四种GFR标志物。
在所有四种标志物中,CysC最能反映CKD 1期的肾小球损伤程度。根据rGFR,由五种不同公式得出的GFR估算值(eGFR)要么高估要么低估了GFR,偏差程度取决于性别、年龄和CKD分期。无论性别和年龄差异如何,Counahan-Barratt公式和Schwartz公式分别对CKD 1期和2-3期的GFR给出了最准确的估算。受试者工作特征分析表明,Counahan-Barratt公式具有最高的诊断准确性。
Counahan-Barratt公式最接近rGFR,因此对不同性别、年龄和CKD分期的中国CKD患儿适用性最高。